Patterns of symptom complaints in methadone maintenance patients

Addiction

Volumn 92, Issue 11, 1997, Pages 1445-1455

  Dyer, Kyle R ^a,b   White, Jason M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Natl Ctr Educ Train on Addict   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHADONE; MORPHINE;

ADULT; ARTICLE; AUSTRALIA; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; SYMPTOM; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 0030664956     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.1997.tb02866.x     Document Type: Article

References (29)

1. BALE, R. (1979) The validity and reliability of self-reported data from heroin addicts: mailed questionnaires compared with face to face interviews, International Journal of the Addictions, 14, 993-1000.
2. BELL, J., SERES, B., BOWRON, P., LEWIS, J. & BATEY, R. (1988) The use of serum methadone levels in patients receiving methadone maintenance, Clinical Pharmacology and Therapeutics, 43, 623-629.
3. BELL, J., SERES, B., BOWRON, P., LEWIS, J. & BATEY, R. (1990) Serum levels of methadone in maintenance clients who persist in illicit drug use, British Journal of Addiction, 85, 1599-1602.
4. BLOOM, W. & BUTCHER, B. (1970) Methadone side effects and related symptoms in 200 methadone maintenance patients, Proceedings of the 3rd National Conference on Methadone Treatment, pp 44-49 (Washington, DC, Government Printing Office).
5. BLUM, K. & HOLDER, J. (1984) Handbook of Abusable Drugs (Lake Worth, Florida, Gardner Press).
6. CHILDRESS, A. R., MCLELLAN, A. & O'BRIEN, C. (1986) Conditioned responses in a methadone population. A comparison of laboratory, clinic and natural settings, Journal of Substance Abuse Treatment, 3, 173-179.
7. CICERO, T., BELL, R., WIEST, W., ALLISON, J., POLAKOSKI, K. & ROBINES, E. (1975) Function of the male sex organs in heroin and methadone users, New England Journal of Medicine, 292, 882-887.
8. DOBRIN, E. & MARES, S. (1974) Effects of morphine on serum gonadotrophin levels, in: SINGH, J. & LAL, H. (Eds) Drug Addiction: new aspects of analytical and clinical toxicology, 4th edn, pp 69-78 (New York, Stratton Intercontinental Medical Books).
9. DOLE, V. P. (1994) Methadone maintenance: optimizing dosage by estimating plasma level, Journal of Addictive Diseases, 13, 1-4.
10. GOLDSTEIN, A. & JUDSON, B. (1973) Efficacy and side effects of three widely different methadone doses, Proceedings of the Fifth National Conference on Methadone Treatment, National Association for the Prevention of Addiction to Narcotics, March 17-19, 1973.
11. HAERTZEN, C. & HICKEY, J. (1987) Addiction Research Centre Inventory (ARCI): measurement of euphoria and other drug effects, in: BOZARTH, M. (Ed.) Methods of Assessing the Reinforcing Properties of Abused Drugs (New York, Springer Verlag).
12. HOLMSTRAND, J., ANGAARD, E. & GUNNE, L. (1978) Methadone maintenance: plasma levels and therapeutic outcome, Clinical Pharmacology and Therapeutics, 23, 175-180.
13. JUDSON, B. & GOLDSTEIN, A. (1982) Symptom complaints of patients maintained on methadone, LAAM and naltrexone at different times in their addiction careers, Drug and Alcohol Dependence, 10, 269-282.
14. KREEK, M. (1973) Medical safety and side effects of methadone in tolerant individuals, Journal of the American Medical Association, 223, 665-668.
15. KREEK, M. (1979) Methadone in treatment: physiological and pharmacological issues, in: DUPONT, R., GOLDSTEIN, A. & O'DONNELL, J. (Eds) Handbook on Drug Abuse (Rockville, MD, NIDA).
16. KREEK, M. (1992) Rational for maintenance pharmacotherapy of opiate dependence, in: O'BRIEN, C. & JAFFE, J. (Eds) Addictive States, pp 205-230 (New York, Raven Press).
17. KREEK, M. (1995) Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid agonists, in: SCHUSTER, C. & KUHAR, M. (Eds) Pharmacological Aspects of Drug Dependence: toward an integrated neuro-behavioral approach, pp 487-561 (New York, Springer).
18. LAFISKA, S., BOLELLI, G., FRANCESCHETTI, F., FILICORI, M., FLAMIGNI, C. & MARIGO, M. (1981) Hormone levels in methadone treated drug addicts, Drug and Alcohol Dependence, 8, 229-234.
19. LOIMER, N. & SCHMID, R. (1992) The use of plasma levels to optimize methadone maintenance treatment, Drug and Alcohol Dependence, 30, 241-246.
20. LONGWELL, B., KESTLER, R. & COX, T. (1979) Side effects in methadone patients: a survey of self-reported complaints, International Journal of the Addictions, 14, 485-494.
21. MARTIN, J., PAYTE, J. & ZWEBEN, J. (1991) Methadone maintenance treatment: a primer for physicians, Journal of Psychoactive Drugs, 23, 165-176.
22. MENDELSON, J. H., MENDELSON, J. E. & PATCH, V. D. (1975) Plasma testosterone levels in heroin addiction and during methadone maintenance, Journal of Pharmacology and Experimental Therapeutics, 192, 211-217.
23. MIRIN, S., MEYER, R., MENDELSON, J. H. & ELLINGBOE, J. (1973) Opiate use and sexual function, American Journal of Psychiatry, 8, 909-915.
24. PENNEBAKER, J. & SKELTON, J. (1978) Psychological parameters of physical symptoms, Personality Social Psychology Bulletin, 4, 524-530.
25. REYNOLDS, I. & MAGRO, D. (1975) The Use of Methadone as a Treatment Tool for Opiate Addicts: a two-year follow-up study (Sydney, Health Commission of NSW).
26. SAWE, J. (1986) High-dose morphine and methadone in cancer patients, Clinical Pharmacokinetics, 11, 87-106.
27. TENNANT, F. (1987) Inadequate plasma concentrations in some high-dose methadone maintenance patients, American Journal of Psychiatry, 144, 1349-1350.
28. WHITEHEAD, C. (1974) Methadone Pseudowithdrawal Syndrome: paradigm for a psychopharmacological model of opiate addiction, Psychosomatic Medicine, 36, 189-198.
29. WINTERS, K., STINCHFIELD, R., HENLY, G. & SCHWARTZ, R. (1991) Validity of adolescent self-report of alcohol and other drug involvement, International Journal of the Addictions, 25, 1379-1395.